Genelux (GNLX) Change in Acquisitions & Divestments (2024 - 2026)
Genelux (GNLX) posted quarterly Change in Acquisitions & Divestments of $6.8 million for Q1 2026, up 13.0% year-over-year from $6.0 million in Q1 2025, and down 3.14% quarter-over-quarter from $7.0 million in Q4 2025.
Genelux (GNLX) Change in Acquisitions & Divestments (2024 - 2026) Analysis & Trends
Genelux's Change in Acquisitions & Divestments history runs 3 years deep, the most recent figure standing at $6.8 million for Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments rose 13.0% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $32.3 million (up 25.36% YoY), while the FY2025 annual figure was $31.5 million, up 48.24% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $6.8 million, down from $7.0 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $10.5 million in Q3 2025, with the low at $1.5 million in Q1 2024.
- The 3-year median for Change in Acquisitions & Divestments is $6.8 million (2026), against an average of $6.6 million.
- Peak annual rise in Change in Acquisitions & Divestments reached 300.0% in 2025, while the deepest fall reached 3.45% in 2025.
- Genelux's Change in Acquisitions & Divestments stood at $7.2 million in 2024, then slipped by 3.45% to $7.0 million in 2025, then decreased by 3.14% to $6.8 million in 2026.
- Business Quant data shows GNLX's Change in Acquisitions & Divestments at $6.8 million in Q1 2026, $7.0 million in Q4 2025, and $10.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Genelux | 119.87 Mn | 119.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.78 Mn |
| Mar 31, 2026 | 6.78 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Sep 30, 2025 | 10.50 Mn |
| Sep 30, 2025 | 10.50 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | 7.25 Mn |
| Dec 31, 2024 | 7.25 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Jun 30, 2024 | 6.50 Mn |
| Jun 30, 2024 | 6.50 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.50 Mn |